Blood Stream Infections
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Evaluation of MiSeq for Microbial Identification in Specimens
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric Patients
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres
Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility
Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility